Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Minicircle DNA vaccine design and application

A technology of pathogenic microorganisms and antigens, applied in the design and application of microcircle DNA vaccines, can solve the problems of DNA vaccines such as low immunogenicity, low transfection efficiency, and limited antigenic protein, so as to enhance immunogenicity and avoid safety problems , the effect of efficient expression

Inactive Publication Date: 2019-12-13
SYNO MINICIRCLE BIOTECH CO LTD
View PDF9 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The low transfection efficiency of plasmids and the limited production of antigenic proteins in the host body are the fundamental reasons for the low immunogenicity of DNA vaccines

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Minicircle DNA vaccine design and application
  • Minicircle DNA vaccine design and application
  • Minicircle DNA vaccine design and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Embodiment 1, minicircle DNA parent plasmid construction

[0039] 1) Synthesizing a full-length target gene DNA fragment, the target gene is selected from coding gene sequences such as Bacillus anthracis PA, HPV E6 / E7 chimeric protein, HPV L1 protein, HPV L2 protein or HPV L1 / L2 chimeric protein (such as SEQ ID NO : 7-11).

[0040] 2) Subcloning the target gene fragment into the attB and attP sites of the minicircle DNA empty vector to construct the minicircle DNA master plasmid. The minicircle DNA parent plasmid contains attB and attP recombination sites, 32 tandem repeated I-SceI restriction sites (I-SceI*32), kana resistance gene, SV40 DNA nuclear targeting sequence (DNA nuclear targeting sequence, DTS), CMV promoter / enhancer, chimeric intron, target gene, bovine growth hormone (bGH) poly A signal.

Embodiment 2

[0041] Embodiment 2, microcircle DNA preparation

[0042] 1) The minicircular DNA master plasmid was transformed into genetically engineered E coli bacteria ZYCY10P3S2T (Nature Biotechnology 2010, 28:1287-9).

[0043] 2) Inoculate the ZYCY10P3S2T containing the minicircle master plasmid into the TB medium containing kana, culture it on a shaker at 37°C for 12-16h, and the bacteria will produce a large amount of minicircle DNA master plasmid.

[0044] 3) Add the induction medium containing arabinose, and under the induction of arabinose (32° C. shaker culture for 8 h), ZYCY10P3S2T expresses the ΦC31 recombinase and the endonuclease that recognizes the I-SceI site. Under the action of ΦC31 recombinase, the minicircle DNA parent plasmid undergoes DNA recombination at the attB / attP recombination site to form two small circular DNA molecules: i) minicircle DNA (only contains the target gene expression cassette and 36-bp attR site); ii) a small circle composed of plasmid backbone D...

Embodiment 3

[0046] Embodiment 3, Western Blot detection protein (Bacillus anthracis PA antigen) expression

[0047] 1. Experimental steps

[0048] 1) Prepare protein samples: use liposome transfection reagent (such as Lipofectamine 2000) to transfect microcircle DNA or equimolar microcircle DNA master plasmid into 293T cells, replace serum-free cell culture medium, and culture in serum-free medium Three days later, the culture supernatants of 293T cells were collected respectively.

[0049] 2) Electrophoresis: After adding an appropriate amount of loading buffer to the protein sample, heat it in boiling water for 3-5 minutes to denature the protein. After cooling, add the sample to the sample well of the SDS-PAGE gel, and electrophoresis at 80-100V for 1 hour.

[0050] 3) Membrane transfer: transfer the protein from the SDS-PAGE gel to the PVDF membrane using a wet transfer device (Bio-Rad, USA) at 300 mA for 1 hour.

[0051] 4) Blocking: After washing the PVDF membrane, add Western Blo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to minicircle DNA vaccine design and application. Specifically, the invention relates to a minicircle DNA vector for expressing specific antigens or antigen fragments of pathogenic microorganisms in vivo. The minicircle DNA vector can mediate antigen proteins to be efficiently expressed in vivo, the immunogenicity of DNA vaccines is enhanced, and meanwhile, the safety problemcaused by resistance genes can be avoided. The minicircle DNA vector can be used for preventing and / or treating common infectious diseases and related cancers, and has the advantages of stronger antigen expression and higher safety.

Description

technical field [0001] The invention belongs to the field of biomedicine, in particular to a minicircle (Minicircle, MC) DNA carrier, more specifically to the design and application of a minicircle DNA vaccine. Background technique [0002] Vaccines refer to biological agents that can stimulate the body to effectively produce acquired immunity against specific diseases, and are generally composed of inactivated or attenuated pathogens, toxins, pathogenic proteins or polypeptides. The closest technology to the present invention is plasmid based DNA vaccines. With the development of immunology, studies have found that direct introduction of recombinant plasmids carrying antigen-encoding genes into human or animal bodies, using host cells to synthesize antigenic proteins, can induce the body to produce antigen-specific humoral and cellular immune responses, thereby preventing or treating diseases . [0003] DNA vaccines have distinct advantages, and there are more and more pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/63C12N15/66C07K14/32C07K14/025A61K39/07A61P31/04A61P35/00
CPCA61K39/07A61K2039/53A61K2039/55511A61K2039/575A61P31/04A61P35/00C07K14/005C07K14/32C12N2710/20022
Inventor 谌平谢亦武陈志英
Owner SYNO MINICIRCLE BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com